These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11299054)

  • 1. Future of adenoviruses in the gene therapy of arthritis.
    Evans CH; Ghivizzani SC; Oligino TA; Robbins PD
    Arthritis Res; 2001; 3(3):142-6. PubMed ID: 11299054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.
    Schulick AH; Vassalli G; Dunn PF; Dong G; Rade JJ; Zamarron C; Dichek DA
    J Clin Invest; 1997 Jan; 99(2):209-19. PubMed ID: 9005989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging adenoviral vectors for stable correction of genetic disorders.
    Jager L; Ehrhardt A
    Curr Gene Ther; 2007 Aug; 7(4):272-83. PubMed ID: 17969560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome.
    Fisher KJ; Kelley WM; Burda JF; Wilson JM
    Hum Gene Ther; 1996 Nov; 7(17):2079-87. PubMed ID: 8934222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors.
    Kolls JK; Lei D; Odom G; Nelson S; Summer WR; Gerber MA; Shellito JE
    Hum Gene Ther; 1996 Mar; 7(4):489-97. PubMed ID: 8800743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of optimal transduction of primary human skin keratinocytes by viral vectors.
    Gagnoux-Palacios L; Hervouet C; Spirito F; Roques S; Mezzina M; Danos O; Meneguzzi G
    J Gene Med; 2005 Sep; 7(9):1178-86. PubMed ID: 15880606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
    Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
    Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.
    Dong JY; Wang D; Van Ginkel FW; Pascual DW; Frizzell RA
    Hum Gene Ther; 1996 Feb; 7(3):319-31. PubMed ID: 8835219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapeutic approaches-transfer in vivo.
    Evans CH; Gouze E; Gouze JN; Robbins PD; Ghivizzani SC
    Adv Drug Deliv Rev; 2006 May; 58(2):243-58. PubMed ID: 16563557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vectors for gene therapy.
    Robbins PD; Ghivizzani SC
    Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver.
    Yao SN; Farjo A; Roessler BJ; Davidson BL; Kurachi K
    Viral Immunol; 1996; 9(3):141-53. PubMed ID: 8890472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors.
    Keriel A; René C; Galer C; Zabner J; Kremer EJ
    J Virol; 2006 Feb; 80(3):1487-96. PubMed ID: 16415025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenovirus, a gene therapy vector: application to lung diseases].
    Perricaudet M; Stratford-Perricaudet LD
    Bull Acad Natl Med; 1995 Mar; 179(3):463-75; discussion 475-7. PubMed ID: 7648295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System for efficient helper-dependent minimal adenovirus construction and rescue.
    Hillgenberg M; Schnieders F; Löser P; Strauss M
    Hum Gene Ther; 2001 Apr; 12(6):643-57. PubMed ID: 11426464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
    Schagen FH; Ossevoort M; Toes RE; Hoeben RC
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.